Brussels, 16/07/2014 (Agence Europe) - Several organisations working in access to medicines and health (Health Action International Europe, International Society of Drug Bulletins, Medicines in Europe Forum and the Association internationale de la Mutualité) have criticised the actions of the European Medicines Agency (EMA) which, in exchange for a fee, has been providing pharmaceutical companies with advice on their development plans for new medicines. The EMA is now trying to extend these...